Lipid Nanoparticle Formulations for the Skin Delivery of Cannabidiol [PDF]
PharmaceuticsBackground/Objectives: The aims of this work were to formulate cannabidiol in different lipid carriers for skin delivery after topical application and to study their stability, interaction with the skin, and antibacterial activity.
Maria Natalia Calienni +8 more
doaj +2 more sources
Todo lo que debemos saber sobre el cannabidiol [PDF]
, 2021 Dos años atrás, la madre de un paciente que padecía simultáneamente una esquizofrenia y una adicción al cannabis buscaba desesperadamente marihuana rica en Cannabidiol (CBD). Sabía que uno de los componentes del cannabis, el Tetra-hidro-cannabinol (THC),
Gual, Antoni, López Pelayo, Hugo
core +2 more sources
THERAPEUTIC POTENTIAL OF CANNABIDIOL: THE MOST IMPORTANT ACHIEVEMENTS ON THE WAY TO A NEW ERA
Медична наука України, 2023 Background. Cannabidiol (CBD), found in Cannabis sativa (hemp), is a non-psychoactive phytochemical substance that has gained considerable popularity over the past decade. Cannabidiol is the main phytocannabinoid, its share in the plant extract can reach
M.M. Shevchuk, L.I. Volos
doaj +1 more source
Frontiers in Cellular Neuroscience, 2021 The protective effect of Cannabidiol on Parkinson’s disease (PD) has been found in recent study. However, the specific mechanism of the protective effect of Cannabidiol on PD nerve damage require further exploration. This study aims to investigate effect
Shaolei Kang +4 more
doaj +1 more source
Effectiveness and safety of cannabidiol in adult patients with epilepsy: A multicenter, retrospective study. [PDF]
Epilepsia OpenAbstract Objective Cannabidiol (CBD) has demonstrated promising effectiveness and tolerability as adjunctive treatment in patients with severe childhood epilepsies. This study investigated the effectiveness and tolerability of CBD in adults with a history of Dravet syndrome (DS), Lennox–Gastaut syndrome (LGS), or tuberous sclerosis complex (TSC ...
Sánchez-Gamino S +7 more
europepmc +2 more sources
A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021
Frontiers in Pharmacology, 2022 Cannabidiol, a non-psychoactive component extracted from the plant cannabis sativa, has gained growing focus in recent years since its extensive pharmacology effects have been founded.
Liu Liu +6 more
doaj +1 more source
Effect of combining CBD with standard breast cancer therapeutics
Advances in Cancer Biology - Metastasis, 2022 Breast cancer is the most common malignancy in women worldwide. Sixty-five percent of breast cancers are estrogen and/or progesterone receptor positive.
Luka Dobovišek +5 more
doaj +1 more source
Combination therapy with cannabidiol and chemotherapeutics in canine urothelial carcinoma cells.
PLoS ONE, 2021 BackgroundCanine urothelial carcinoma is the most common form of canine bladder cancer. Treatment with chemotherapy has variable response rates leading to most dogs succumbing to their disease within a year.
Jordon M Inkol +2 more
doaj +2 more sources
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration. [PDF]
PLoS ONE, 2014 Disc degeneration is a multifactorial process that involves hypoxia, inflammation, neoinnervation, accelerated catabolism, and reduction in water and glycosaminoglycan content.
João W Silveira +7 more
doaj +1 more source
Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice [PDF]
, 2012 Background/Aims: Compounds of Cannabis sativa are known to exert anti-inflammatory properties, some of them without inducing psychotropic side effects. Cannabidiol (CBD) is such a side effect-free phytocannabinoid that improves chemically induced colitis
Martin Storr +3 more
core +1 more source